No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia

Keyphrases

• Long-term Survivors 100%
• Childhood Acute Lymphoblastic Leukemia 100%
• Prednisolone 100%
• Dexamethasone Treatment 100%
• Bone Mineral Density 100%
• Mineral Growth 100%
• Prednisolone Treatment 100%
• Body Composition 50%
• Lumbar Spine 50%
• Irradiation 33%
• Cranial Irradiation 33%
• Standard Deviation Score 33%
• Body Mass Index Standard Deviation Score 33%
• Lean Body Mass 33%
• Total-body 33%
• Bone Mineral Apparent Density 33%
• Increased Body Mass Index 33%
• Leukemia 16%
• First Complete Remission 16%
• Body Growth 16%
• Dual-energy X-ray Absorptiometry 16%
• High Incidence 16%
• Multicenter Cohort Study 16%
• Body Fat Percentage 16%
• Bone Size 16%
• Irradiated Patients 16%
• Target Height 16%

Medicine and Dentistry

• Acute Lymphoblastic Leukemia 100%
• Dexamethasone 100%
• Prednisolone 100%
• Bone Density 100%
• Lumbar Spine 42%
• Skull Irradiation 28%
• Body Mass Index 28%
• Bone Mineral 28%
• Lean Body Weight 28%
• Acute Lymphocytic Leukemia 28%
• Dual-Energy X-Ray Absorptiometry 14%
• Body Fat Percentage 14%
• Side Effect 14%

Immunology and Microbiology

• Dexamethasone 100%
• Prednisolone 100%
• Bone Density 100%
• Body Composition 42%
• Lumbar Spine 42%
• Body Mass 28%
• Lean Body Weight 28%
• Bone Mineral 28%
• X Ray 14%
• Body Fat 14%
• Body Growth 14%